- Trials with a EudraCT protocol (4,216)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (372)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: J Child Neurol. 1994 Apr;9(2):155-61. Neuroimaging in infantile autism. Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28204 |
| Study title: J Clin Oncol. 2005 May 1;23(13):3030-7. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, Schmiegelow K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28104 |
| Study title: Pediatr Radiol. 2004 Mar;34(3):190-8. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. Hudson MM, Krasin MJ, Kaste SC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28137 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):23-7. Cancer screening with FDG-PET. Ide M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28085 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera. Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28084 |
| Study title: Radiology. 1998 Oct;209(1):253-8. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28189 |
| Study title: Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44045 |
| Study title: Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43590 |
| Study title: Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43363 |
| Study title: Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43825 |
| Study title: Stereotact Funct Neurosurg. 1995;64 Suppl 1:258-69. Early irradiation effects observed on magnetic resonance imaging and angiography, and positron emission tomography for arteriovenous malformations treated by Gamma Knife radiosurgery. Guo WY, Pan DH, Liu RS, Chung WY, Shiau CY, Cheng SS, Chang CY, Chen KY, Yeh SH, Lee LS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28200 |
| Study title: Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43962 |
| Study title: Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43484 |
| Study title: Nuclear imaging and clinical features of childhood reflex neurovascular dystrophy: comparison with adults. Goldsmith DP, Vivino FB, Eichenfield AH, Athreya BH, Heyman S. Arthritis Rheum. 1989 Apr;32(4):480-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43789 |
| Study title: Biomed Pharmacother. 2006 Nov;60(9):593-606. Epub 2006 Sep 1.18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours.Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Rampin L, Gross MD, Al-Nahhas A, Fanti S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28075 |
| Study title: Br J Cancer. 2004 Feb 9;90(3):620-5. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hänel A, Bredow J, Kühnel G, Kropp J, Hänel M, Laniado M, Kotzerke J, Ehninger G. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28136 |
| Study title: Brain Dev. 2001 Dec;23 Suppl 1:S62-71. Neuroimaging studies in Rett syndrome. Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28164 |
| Study title: Childs Nerv Syst. 2006 Aug;22(8):810-20. Epub 2006 Jun 24. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Sood S, Chugani HT. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28079 |
| Study title: J Neurosurg. 2006 Feb;104(2):238-53. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28087 |
| Study title: J Nucl Med. 1998 Jul;39(7):1302-5. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, Wahl RL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28191 |
| Study title: J Nucl Med. 2001 Aug;42(8):1139-43. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28168 |
| Study title: J Nucl Med. 2003 Aug;44(8):1200-9. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28142 |
| Study title: Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al.. Epub 2004 Dec 30. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? [yen-2005-c]Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Yen TC 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48717 |
| Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis. Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med. 1985 Dec;26(12):1377-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48464 |
| Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H. Strobel K. J Mag Reson Imaging 2007;26:422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48467 |
| Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28140 |
| Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28158 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28152 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28149 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28131 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28133 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28132 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28135 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28098 |
| Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28078 |
| Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28146 |
| Study title: Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87054_study_synopsis.pdf |
| View full study record |
| Document reference: 28821 |
| Study title: Open label study of Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system (CNS) lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88492_study_synopsis.pdf |
| View full study record |
| Document reference: 28831 |
| Study title: Open uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients (6-18 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28829 |
| Study title: Open-Label Study of Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
| View full study record |
| Document reference: 28832 |
| Study title: Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28867 |
| Study title: Open-label, multicenter trial of Magnevist® enteral in magnetic resonance imaging of patients |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): ME90095 ME91005 ME91006.pdf |
| View full study record |
| Document reference: 28825 |
| Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28722 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86238_study_synopsis.pdf |
| View full study record |
| Document reference: 28820 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients, 16-18 years (phase III) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87191_study_synopsis.pdf |
| View full study record |
| Document reference: 28822 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of brain lesions in children (2-6 years) (phase III). |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87224_study_synopsis.pdf |
| View full study record |
| Document reference: 28823 |
| Study title: Uncontrolled multicentre study for the further demonstration of the tolerance and efficacy of dimeglumine gadopentatate on intravenous use in magnetic resonance imaging in adults |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86110_study_synopsis.pdf |
| View full study record |
| Document reference: 28816 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1357 Redacted.pdf |
| View full study record |
| Document reference: 47577 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B) |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1358 Redacted.pdf |
| View full study record |
| Document reference: 47578 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1356 Redacted.pdf |
| View full study record |
| Document reference: 47576 |
| Study title: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28808 |
| Study title: J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28809 |
| Study title: Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28871 |
| Study title: Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28861 |
| Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28868 |
| Study title: Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28852 |
| Study title: Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28840 |
| Study title: Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28843 |
| Study title: Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28850 |
| Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28847 |
